Clinical Report: Utilizing Whole Genome Sequencing for Diagnosis and Healthcare Management in Severely Ill Pediatric Patients
Background
Genetic disorders are significant contributors to morbidity and mortality in children admitted to neonatal and pediatric intensive care units. Whole genome sequencing has emerged as a vital tool in clinical practice for diagnosing rare or monogenic diseases. Understanding the long-term implications of genomic diagnoses on healthcare utilization is crucial for optimizing care in this vulnerable population.
Data Highlights
No specific numerical data or trial results were provided in the source material.
Key Findings
Genetic disorders account for 10% to 30% of admissions to NICUs and PICUs.
WGS has shown a molecular diagnostic yield of 21% to 45% in critically ill pediatric patients.
Short-term health economic studies indicate WGS can reduce PICU costs by shortening hospital stays and avoiding invasive procedures.
More than 90% of clinicians reported increased confidence in patient management after WGS implementation.
Long-term healthcare utilization patterns differ between children with and without identifiable genetic diagnoses.
Clinical Implications
The integration of WGS in pediatric intensive care can enhance diagnostic accuracy.
Conclusion
Whole genome sequencing represents an advancement in the diagnosis and management of severely ill pediatric patients.
Related Resources & Content
Nature Medicine, Citywide Deployment of an Accelerated Whole-Genome Sequencing Initiative for Critically Ill Children, 2026 -- https://www.nature.com/articles/s41591-026-04598-x
the pathologist, The Need for (Sequencing) Speed, 2017 -- https://www.thepathologist.com/issues/2017/articles/dec/the-need-for-sequencing-speed/
the pathologist, A Rare Resolve, 2023 -- https://www.thepathologist.com/issues/2023/articles/jul/a-rare-resolve/
The ASCO Post, Integrating Genomic Sequencing Into Clinical Care, 2013 -- https://ascopost.com/issues/september-1-2013/integrating-genomic-sequencing-into-clinical-care/
Rapid Whole-Genome Sequencing in Critically Ill Infants and Children with Suspected, Undiagnosed Genetic Diseases: Evolution to a First-Tier Clinical Laboratory Test in the Era of Precision Medicine - PMC -- https://pmc.ncbi.nlm.nih.gov/articles/PMC12025730/?utm_source=openai
Molecular diagnostic yield of exome sequencing and genome sequencing in critical ill neonates and infants: A systematic review and meta-analysis - ScienceDirect -- https://www.sciencedirect.com/science/article/pii/S1098360026009457?utm_source=openai
Citywide implementation of a rapid whole-genome sequencing program for critically ill pediatric patients | Nature Medicine -- https://www.nature.com/articles/s41591-026-04598-x
Multi-center implementation of rapid whole genome sequencing provides additional evidence of its utility in the pediatric inpatient setting - PubMed -- https://pubmed.ncbi.nlm.nih.gov/38440187/
Nature Medicine — Citywide Deployment of an Accelerated Whole-Genome Sequencing Initiative for Critically Ill Children
the pathologist — The Need for (Sequencing) Speed
the pathologist — A Rare Resolve
The ASCO Post — Integrating Genomic Sequencing Into Clinical Care
Rapid Whole-Genome Sequencing in Critically Ill Infants and Children with Suspected, Undiagnosed Genetic Diseases: Evolution to a First-Tier Clinical Laboratory Test in the Era of Precision Medicine - PMC
Molecular diagnostic yield of exome sequencing and genome sequencing in critical ill neonates and infants: A systematic review and meta-analysis - ScienceDirect
Citywide implementation of a rapid whole-genome sequencing program for critically ill pediatric patients | Nature Medicine
Multi-center implementation of rapid whole genome sequencing provides additional evidence of its utility in the pediatric inpatient setting - PubMed
by Joao M. L. Dias, Ravi P. More, Duncan Butler, Julian Brown, Courtney E. French, Helen Dolling, F. Lucy Raymond, David H. Rowitch, Catherine E. Aiken
Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.
Phoenix Children’s today announced the appointment of Joshua D. Koch, MD, as Senior Vice President, Hospital Based In Chief, a newly established executive physician leadership role created to strengthen coordination across the health system’s hospital-based clinical services.